How the hydrolytic activity of mitochondrial ATP synthase is modulated during brown adipose tissue (BAT) thermogenesis ...

The lipids market is anticipated to reach a value of USD 9.7 billion by 2022 and then grow at a CAGR of 8.7% from 2022 to ...

Use Filtration Assemblies Market is predicted to be worth US$ 3.53 billion in 2023 and rise to US$ 19.28 billion by 2033. Initially, the global market was expanding at a CAGR of 19.8% from 2018 to ...

Coverslips were coated with 0.01% poly-l-lysine (Merck Millipore) for 20 min at RT. The iRBCs were gently added to the ...

Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, ...

Trailhead Biosystems, Inc. (trailbio.com), a biotechnology company creating iPSC-derived human cells at scale for drug discovery and cell therapy, welcomes Josh Snow as Chief Commercial Officer.

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

In 2021, the FDA blasted Merck for using a premature endpoint to pursue a Keytruda approval in early-stage triple-negative breast cancer (TNBC). Now, the PD-1 inhibitor has gold-standard overall ...

This marks Keytruda's first approval for the given indication. Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.